Abstract: A secure media capture device may comprise a secure memory, a first sensor, a second sensor, a processor, and a communication module. The first sensor may be configured to capture media. The second sensor may be configured to capture data indicating a time, a place, or a combination thereof at which the media is captured. The processor may be configured to obtain device metadata; associate the data, the media, and the device metadata to form a submission; encrypt the submission; and store the submission in the secure memory The communication module may be configured send to the submission to a public web server via a public network.

Abstract: The present invention provides a recombinant gram-negative bacterial cell comprising an expression vector comprising a recombinant polynucleotide encoding DsbC and one or more polynucleotides encoding an antibody or an antigen-binding fragment thereof specifically binding to CD154.

Abstract: Embodiments of the invention provide a control system for a hybrid electric vehicle, the vehicle having a powertrain comprising at least one electric propulsion motor and at least one engine, the control system being operable to control the vehicle to operate in an electric vehicle (EV) mode in which the at least one engine remains switched off and the at least one electric propulsion motor is configured to deliver drive torque and a boost mode in which the at least one engine is switched on to provide additional power to drive the vehicle. When the vehicle is operating in EV mode the system is further operable to determine whether a boost location exists ahead of the vehicle being a location at which a gradient of a driving surface is sufficiently high to require selection of the boost mode, the control system being operable automatically to command starting of the at least one engine before the boost location is reached.

Abstract: The subject matter disclosed herein provides methods for assessing potential safety and security risks by measuring a test subject's implicit affinity for violence or extremism. A series of sorting tasks can be generated for a user of a computer associated with a machine. At least two digital representations of association categories can be provided. A sequence of two or more trials can be executed. Each trial can provide a randomly-selected digital representation of a stimulus that can provide at least two digital representations of association categories; receive a selection by the user in response to the stimulus; and record a time between providing the randomly-selected digital representation of the stimulus and receiving the selection by the user. A score can be calculated reflecting the strength of the user's implicit association between one pair of identity-related and violence- or extremism-related categories and a different pair.

Abstract: The present invention provides a recombinant gram-negative bacterial cell comprising an expression vector comprising a recombinant polynucleotide encoding DsbC and one or more polynucleotides encoding an antibody or an antigen-binding fragment thereof specifically binding to CD154.

Abstract: The invention relates to a control system for a hybrid electric vehicle (100), the vehicle having a powertrain (135) comprising at least one electric propulsion motor (123) and at least one engine (121), the control system being operable to control the vehicle to operate in an electric vehicle (EV) mode in which the at least one engine remains switched off and the at least one electric propulsion motor is configured to deliver drive torque and a boost mode in which the at least one engine is switched on to provide additional power to drive the vehicle. When the vehicle is operating in EV mode the system is further operable to determine whether a boost location exists ahead of the vehicle being a location at which a gradient of a driving surface is sufficiently high to require selection of the boost mode, the control system being operable automatically to command starting of the at least one engine before the boost location is reached.

Abstract: In an aspect of the invention there is provided a speed control system for a hybrid electric vehicle, the vehicle having at least one engine and at least, one electric machine, the system being operable to allow a driver to set a target vehicle speed, the system being operable in first and, second speed control modes to control the vehicle to maintain the target vehicle speed, in the first speed control mode the system being configured to limit operation of the vehicle to an electric vehicle (EV) mode, in the second speed control mode the system being configured not to limit operation of the vehicle to the EV mode, wherein when the control system is in the first mode and at least one of a prescribed one or more conditions is met, e.g. a rate of acceleration demanded by the driver or a difference between a target vehicle speed and a current vehicle speed exceeds a respective prescribed threshold value, the system is operable to not limit operation of the vehicle to the EV mode.

Abstract: The invention provides a speed control system and method for a hybrid electric vehicle, the vehicle having an engine (121), an electric machine (123) and a mode switch (169), to allow switching between a first speed control mode (EV) and a second speed control mode (HEV). When the control system is in the first mode and at least one of a prescribed one or more conditions is met, e.g. a rate of acceleration demanded by the driver or a difference between a target vehicle speed and a current vehicle speed exceeds a respective prescribed threshold value, the system is operable to not limit operation of the vehicle to the EV mode.

Abstract: The present invention provides a recombinant gram-negative bacterial cell comprising an expression vector comprising a recombinant polynucleotide encoding DsbC and one or more polynucleotides encoding an antibody or an antigen-binding fragment thereof specifically binding to CD154.

Abstract: The present invention relates to a computerized system for and methods of securely providing precision healthcare services related to the AI-optimized prescribing and monitoring of behavioral health homework at a distance. The system is continually learning in a recursive manner such that the output of one set of patient experiences are added to the AI system to further refine future patient recommendations with regard to prescribed homework assignments. The present invention is unlimited with regard to the type of patient entity or healthcare professional entity.

Abstract: The present invention relates to a computerized system for and method of providing precision healthcare services such as consultation, education, assessment, diagnosis, intervention, or treatment at a distance via encrypted real-time image and audio presence where the healthcare professional's assessment, diagnosis, and intervention activities are informed by patient feedback, smart objects, and artificial intelligence and patient outcomes are optimized through recursive system feedback. The present invention is unlimited with regard to the type of patient entity or healthcare professional entity.

Abstract: The invention relates to an adaptive cruise control (ACC) system for a host motor vehicle having regenerative braking means (122) and non-regenerative braking means. The system is operable to control a powertrain and the braking means of the host vehicle to maintain the vehicle at a target distance (d_target) behind the followed vehicle, the target distance being substantially equal to a second distance that is greater than a first distance (d_driver); and employ substantially only the regenerative braking means and not the non-regenerative braking means to slow the host vehicle when the host vehicle is greater than the first distance (d_driver) behind the followed vehicle and the ACC system determines that braking is required to maintain the vehicle at the target distance.

Abstract: The present invention provides a recombinant gram-negative bacterial cell comprising a mutant spr gene encoding a spr protein having a mutation at one or more amino acids selected from D133, H145, H157, N31, R62, 170, Q73, C94, S95, V98, Q99, R100, L108, Y115, V135, L136, G140, R144 and G147 and wherein the cell has reduced Tsp protein activity compared to a wild-type cell.

Abstract: A recombinant gram-negative bacterial cell comprising one or more of the following mutated protease genes: a) a mutated Tsp gene, wherein the mutated Tsp gene encodes a Tsp protein having reduced protease activity or is a knockout mutated Tsp gene; b) a mutated ptr gene, wherein the mutated ptr gene encodes a Protease III protein having reduced protease activity or is a knockout mutated ptr gene; and c) a mutated DegP gene encoding a DegP protein having chaperone activity and reduced protease activity; wherein the cell is isogenic to a wild-type bacterial cell except for the mutated Tsp gene and/or mutated ptr gene and/or mutated DegP gene and optionally a polynucleotide sequence encoding a protein of interest.

Abstract: A secure media capture device may comprise a secure memory, a first sensor, a second sensor, a processor, and a communication module. The first sensor may be configured to capture media. The second sensor may be configured to capture data indicating a time, a place, or a combination thereof at which the media is captured. The processor may be configured to obtain device metadata; associate the data, the media, and the device metadata to form a submission; encrypt the submission; and store the submission in the secure memory The communication module may be configured send to the submission to a public web server via a public network.

Abstract: A network interface connector includes a plurality of first and second alternating elongate contacts having contact portions situated in a common plane. The first and second contacts have rearward portions situated in respective first and second spaced parallel planes defining a proximity gap between them. A proximity insert having a particular electrical construction suited for a particular application is situated, preferably in a replaceable manner, in the proximity gap to provide the connector with desired transmission properties.

Abstract: The present invention provides a recombinant gram-negative bacterial cell, characterized in that the cell comprises a recombinant polynucleotide encoding DsbC and has reduced Tsp protein activity compared to a wild-type cell.

Abstract: The present invention provides a recombinant gram-negative bacterial cell comprising a mutant spr gene encoding a mutant spr protein and wherein the cell comprises a non-recombinant wild-type chromosomal Tsp gene.

Abstract: The invention relates to a transcriptionally active recombinant linear polynucleotide encoding a multimeric protein comprising in the following order, a first promoter sequence, a first encoding polynucleotide sequence, a bidirectional regulatory sequence, a second encoding polynucleotide sequence and a second promoter sequence, wherein the first and second encoding polynucleotide sequences are in convergent transcriptional orientation, each encoding polynucleotide sequence encodes a component of the multimeric protein and the bidirectional regulatory sequence is operably linked to the first and second encoding polynucleotide sequences and the multimeric protein is an antibody or fragment thereof and each encoding polynucleotide sequence encodes one or more antibody domains or fragments thereof.

Abstract: A recombinant gram-negative bacterial cell comprising one or more of the following mutated protease genes: a) a mutated Tsp gene, wherein the mutated Tsp gene encodes a Tsp protein having reduced protease activity or is a knockout mutated Tsp gene; b) a mutated ptr gene, wherein the mutated ptr gene encodes a Protease III protein having reduced protease activity or is a knockout mutated ptr gene; and c) a mutated DegP gene encoding a DegP protein having chaperone activity and reduced protease activity; wherein the cell is isogenic to a wild-type bacterial cell except for the mutated Tsp gene and/or mutated ptr gene and/or mutated DegP gene and optionally a polynucleotide sequence encoding a protein of interest.